Fact.MR Says, Growth of Keratoprosthesis Market Steered by Increasing Incidences of Corneal Blindness

Fact.MR, a global research firm, in its latest study on the global keratoprosthesis market shall register a remarkable CAGR in 2021 & beyond. Exponential growth in the usage of medical devices as a result of continued progressions in design has prompted increase in the usage of keratoprosthesis. With governments all over the world highly investing in healthcare infrastructure, the keratoprosthesis market is anticipated to foresee a notable growth in the forthcoming years.  

Increasing geriatric population together with growing incidence of eye diseases all over the world shall be the key aspect fuelling the expansion of global keratoprosthesis market. Additionally, increasing incidences of trauma cases are swelling the chances of eye injury which will in addition contribute in fuelling the demand of keratoprosthesis.” states Fact.MR.

Continued Advances in Design & Superior Operative Care to Create Potential Growth Prospects

Keratoprosthesis has advanced in recent years owing to product improvement and drop in side effects of keratoplasty. The expansion of the ophthalmology sector can be accredited to periodic launch of novel technologies in the area of ophthalmic surgery. The preference and need for enhanced health care facilities have generated prospects for commercialization and development of surgical platforms.

Fact.Mr also indicated that keratoprosthesis indications have increased significantly in recent years as well as post-operative complications have brought down with modifications in design of prosthesis and postoperative regimen. As per an article published by the Indian Journal of Ophthalmology, the previous decade has foreseen a rise in several keratoprosthesis procedures performed across the world.

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=859

Boston Keratoprosthesis (KPro) Will Remain Lucrative

Boston Kpro is expected to grow exponentially in 2021 and beyond owing to its widespread utilization of artificial cornea or keratoprosthesis. Continued progressions in superior postoperative care and design have ensued in enhanced outcomes as well as an exponential rise in the usage of the device in the forthcoming years. Furthermore, these and other advances are why the Boston KPro type I is at present the most extensively implanted keratoprosthesis globally.

The WHO indicates that about 8 Mn individuals worldwide suffer from corneal blindness with the most of them living in emerging nations. Pilot projects have been accompanied in multiple nations comprising China, India, Ethiopia and Sudan with preliminary but favourable results.

The US will continue to Contribute Highest Revenue Shares

The US is anticipated to contribute majority of revenue shares, followed by UK while majority of keratoprosthesis surgical procedure are performed in the UK and the US.

China and India are low cost of surgery market for keratoprosthesis, thus it is the ideal place for individuals who are preparing for medical tourism. High occurrence of corneal blindness, and increasing health care infrastructure in these emerging countries, are anticipated to boost demand for keratoprosthesis (KPro) in the regions.

Furthermore, there has been a dramatic rise in demand for cornea implant in UAE & Brazil as a result less adoption of keratoprosthesis surgical procedure in these regions.

Technological Advancements will Remains Prime Focal Aspect: Fact.MR Survey

The competitive landscape of the Keratoprosthesis market reflects a fierce competition. Fact.MR’s survey with thought leaders revealed that merger & acquisition, new product launches and technological advancements will remain key strategies of market players in 2021 & beyond. The updated edition of the report provides comprehensive coverage of the projected to remain the key strategies of market players. Some of the players profiled in the report are Regeneron Pharmaceuticals, Inc., Hoffmann-La Roche Ltd., Pfizer, Inc., Bausch & Lomb Incorporated and Bayer AG. The updated edition also offers a detailed analysis of the COVID-19 impact on this market.

Explore Fact.MR’s Healthcare Reports

https://www.factmr.com/report/4297/non-invasive-surgery-market: Delve into Fact.MR’s extensive study on the non-invasive surgeries market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

https://www.factmr.com/report/4366/basal-cell-carcinoma-treatment-market: The global basal cell carcinoma (BCC) treatment market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

https://www.factmr.com/report/3880/intradermal-injections-market: Fact.MR’s global intradermal injections market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

E: sales@factmr.com

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai, United Arab Emirates

Back to news